Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

CEC levels may be a useful marker for predicting prostate cancer progression.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.